Tag Archives: TNF Inhibitors

June, 2017

November, 2015

  • 20 November

    EU Endorses Biogen and Samsung Bioepis’ Biosimilar Version of Enbrel

    ZUG, Switzerland–(BUSINESS WIRE)–Biogen (NASDAQ:BIIB) today announced further progress as part of its commitment to biosimilars. Samsung Bioepis, the joint venture between Samsung Biologics and Biogen, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the marketing authorization …

October, 2015